Table 3. Cancer-specific standardised incidence ratios (SIRs).
| Cancer site | Birkeland et al, 2000 | Cheung et al, 2012 | Collett et al, 2010 | Hoshida et al, 1997 | Krynitz et al, 2013 | Kyllonen et al, 2000 | Li et al, 2012 | Piselli et al, 2013 | Vajdic et al, 2006 | Vegso et al, 2007 | Villeneuve et al, 2007 | Overall SIR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lip |
13.02 (10.75–15.63) |
|
65.6 (49.9–84.6) |
|
46 (35–59) |
22.95 (12.55–38.51) |
|
9.4 (3.1–22.0) |
47 (41.76–52.91) |
|
31.3 (23.5–40.8) |
29.45 (17.85–48.59) |
| Stomach |
|
2.85 (1.62–5.02) |
2.0 (1.4–2.6) |
1.40 (0.45–2.68) |
1.8 (1.0–2.9) |
|
1.84 (0.83–4.09) |
1.4 (0.8–2.3) |
|
|
2.1 (1.2–3.4) |
1.93 (1.60–2.34) |
| Colon |
|
1.75 (1.22–2.52) |
1.8 (1.6–2.1) |
|
2.3 (1.8–2.9) |
3.94 (2.10–6.74) |
2.04 (1.13–3.54) |
|
1.71 (1.38–2.09) |
0.34 |
1.4 (1.0–1.8) |
1.89 (1.61–2.22) |
| Liver |
|
2.53 (1.63–3.91) |
2.4 (1.5–3.8) |
1.36 (0.24–3.36) |
2.7 (1.6–4.1) |
|
5.07 (3.89–6.42) |
0.4 (0.1–1.1) |
3.19 (1.53–5.8) |
3.25 |
1.8 (0.6–4.3) |
2.63 (1.91–3.62) |
| Pancreas |
|
1.57 (0.51–4.87) |
1.5 (1.2–2.1) |
|
2.2 (1.3–3.5) |
|
|
0.9 (0.3–2.0) |
|
|
1.1 (0.4–2.2) |
1.55 (1.24–1.93) |
| Lunga |
|
1.68 (1.17–2.42) |
1.4 (1.2–1.6) |
|
1.7 (1.3–2.2) |
|
4.81 (2.73–8.48) |
1.1 (0.8–1.6) |
|
0.65 |
2.1 (1.7–2.5) |
1.70 (1.30–2.21) |
| Melanoma |
1·35 (0·28–3·93) |
9.09 (2.27–36.34) |
|
|
|
|
5.40 (0.76–38.18) |
1.8 (0.9–3.3) |
|
|
|
2.33 (1.39–3.92) |
| Non-melanoma skin |
10.68 (8.84–12.79) |
|
16.6 (15.9–17.3) |
|
54 (52–56) |
39.10 (29.20–51.27) |
2.30 (0.86–6.13) |
|
|
2.58 |
|
11.93 (4.84–29.45) |
| Breast |
1.45 (0.72–2.60) |
1.66 (1–2.75) |
1.0 (0.8–1.2) |
1.53 (0.18–5.27) |
1.2 (0.9–1.5) |
1.20 (0.64–2.05) |
|
0.8 (0.5–1.2) |
1.03 (0.78–1.34) |
0.86 |
1.3 (1.0–1.7) |
1.12 (1.00–1.24) |
| Ovary |
|
3.29 (1.37–7.9) |
1.4 (0.9–2.0) |
|
1.9 (1.1–3.1) |
|
1.14 (0.64–1.89) |
1.1 (0.2–3.1) |
1.15 (0.46–2.38) |
|
1.5 (0.6–3.0) |
1.50 (1.19–1.89) |
| Prostate |
|
0.88 (0.39–1.95) |
1.1 (0.9–1.4) |
|
1.1 (0.9–1.3) |
|
|
1.7 (1.2–2.3) |
0.95 (0.68–1.29) |
0.65 |
0.9 (0.6–1.3) |
1.11 (0.99–1.25) |
| Kidney |
4.08 (1.50–8.88) |
12.5 (8.51–18.36) |
7.9 (6.7–9.3) |
79.96 (39.98–114.95) |
6.2 (4.8–7.9) |
7.97 (5.00–12.07) |
|
4.9 (3.4–6.8) |
7.3 (5.69–9.22) |
6.77 |
7.3 (5.7–9.2) |
8.61 (6.73–11.02) |
| Bladder |
1.63 (0.53–3.81) |
8.22 (4.67–14.47) |
2.4 (1.9–3.0) |
6.61 (0.69–20.60) |
2.0 (1.5–2.7) |
3.24 (1.40–6.38 ) |
42.89 (34.08–53.98) |
1.1 (0.7–1.7) |
3.33 (2.4–4.5) |
0.79 |
2.0 (1.3–3.0) |
3.18 (1.34–7.53) |
| Thyroid |
0·91 (0·02–5·09) |
4.35 (2.41–7.85) |
7.0 (4.8–9.8) |
12.43 (2.38–33.70) |
4.1 (2.1–7.2) |
8.09 (4.04–14.47) |
2.41 (1.08–5.34) |
1.9 (0.9–3.6) |
6.9 (4.69–9.8) |
8.95 |
5.0 (3.1–7.4) |
5.29 (3.87–7.24) |
| Hodgkin's lymphoma |
8.0 (1.65–23.38) |
|
7.4 (5.3–10.2) |
|
|
|
|
2.3 (0.5–6.8) |
3.74 (1.51–7.71) |
|
3.6 (1.7–6.9) |
5.92 (4.53–7.73) |
| Non-Hodgkin lymphoma |
5.48 (2.37–10.80) |
|
12.5 (11.2–13.8) |
|
|
|
|
|
9.86 (8.37–11.54) |
1.32 |
8.8 (7.4–10.5) |
6.59 (4.33–10.04) |
| All cancers | 3.59 (3.12–4.11) | 2.94 (2.62–3.29) | 4.5 | 2.78 (1.8–3.28) | 6.5 (6.3–6.8) | 3.33 (2.92–3.79) | 3.75 (3.36–4.18) | 1.7 (1.6–1.9) | 3.4 (3.22–3.59) | 1.33 | 2.5 (2.3–7.1) | 3.19 (2.22–4.60) |
a
Includes trachea, bronchus, and lung.